Saudi Journal of Kidney Diseases and Transplantation

ORIGINAL ARTICLE
Year
: 2017  |  Volume : 28  |  Issue : 3  |  Page : 477--482

Carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysis


Yosuke Aoki1, Takako Yamamoto2 
1 Department of Biochemistry, Institute of Medullasin, Kamakura; Fureai Clinic Izumi, Yokahama, Kanagawa, Japan
2 Department of Biochemistry, Institute of Medullasin, Kamakura, Japan

Correspondence Address:
Yosuke Aoki
Department of Biochemistry, Institute of Medullasin, Kamakura, Kanagawa
Japan

Intravenous administration of 2 g carnitine in every hemodialysis (3 times/week), for 8–10 months, reduced doses of darbepoetin alfa required to maintain adequate hemoglobin levels (10–11 g/dL) into 10% of the initial doses. There was also a significant increase in plasma transferrin saturation, increase in left ventricular ejection fraction, and decrease in plasma brain natriuretic peptides.


How to cite this article:
Aoki Y, Yamamoto T. Carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysis.Saudi J Kidney Dis Transpl 2017;28:477-482


How to cite this URL:
Aoki Y, Yamamoto T. Carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysis. Saudi J Kidney Dis Transpl [serial online] 2017 [cited 2020 Jul 7 ];28:477-482
Available from: http://www.sjkdt.org/article.asp?issn=1319-2442;year=2017;volume=28;issue=3;spage=477;epage=482;aulast=Aoki;type=0